OneMedNet Faces Going Concern Doubt, Nasdaq Delisting Threat Amidst 30% Revenue Drop and Massive Dilution
ONMD has more than doubled off its 52-week low of $0.31 on light trading volume (0.1× avg).
Summary
OneMedNet Corp filed a prospectus supplement incorporating its Q1 2026 results, which disclose a going concern warning, Nasdaq delisting threat, and a 30% revenue decline, alongside plans for highly dilutive share offerings.
Key Events · Financing and Capital Events · ONMD
-
Going Concern Warning Issued
The company's Q1 2026 report states that its cash balance of $0.2 million is insufficient to fund operations for the next 12 months, raising substantial doubt about its ability to continue as a going concern.
-
Nasdaq Delisting Threat
OneMedNet received a notice from Nasdaq on April 14, 2026, regarding non-compliance with the $1.00 minimum bid price rule, initiating a 180-day period to regain compliance and avoid potential delisting.
-
Significant Revenue Decline
Total revenue for Q1 2026 plummeted 30% year-over-year to $96K, primarily due to the decommissioning of its subscription-based BEAM platform.
-
Highly Dilutive Share Offerings
The prospectus supplement facilitates the sale of up to 11.5 million primary shares and 28.15 million secondary shares, representing a potential dilution of over 70% if fully issued, on top of recent related-party capital raises.
Analysis · ONMD · Industrial Applications And Services
This prospectus supplement incorporates the company's Q1 2026 financial results, revealing severe financial distress. The company explicitly states substantial doubt about its ability to continue as a going concern, driven by inadequate cash to fund operations for the next 12 months. Concurrently, it faces a Nasdaq delisting threat due to non-compliance with the minimum bid price rule. Operationally, revenue plummeted 30% year-over-year. The filing also facilitates the potential issuance of up to 39.65 million shares, which could result in over 70% dilution for existing shareholders, highlighting a desperate need for capital. While recent insider and related-party purchases totaling $2.2 million provide a minor counterpoint, the overwhelming financial and operational challenges present a critical negative outlook.
How filings like this one have moved
In the 30 days to Nov 1, 2026, 49% of the 204 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ONMD was trading at $0.84 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $46.2M. The 52-week trading range was $0.31 to $4.22. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.